Spalletta Gianfranco, Bernardini Sergio, Bellincampi Lorenza, Federici Giorgio, Trequattrini Alberto, Ciappi Fabrizio, Bria Pietro, Caltagirone Carlo, Bossù Paola
Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia Foundation, Rome, Italy.
Am J Geriatr Psychiatry. 2007 Oct;15(10):879-87. doi: 10.1097/JGP.0b013e3180547076.
Oxidative stress has been suggested as a contributor of Alzheimer disease (AD) neurodegeneration, particularly in those patients with late-onset AD (LOAD). Therefore, the authors studied the effect of glutathione S-transferase (GST) P1-M1-T1 gene polymorphisms and their interactions with the apolipoprotein E (ApoE) epsilon4 allelic variant on the three-year longitudinal course of AD.
Global cognitive level as measured by the Mini-Mental State Exam, basic activities of daily living (BADLs) as measured by the Physical Self-Maintenance Scale, and behavior as measured by the Neuropsychiatric Inventory, were assessed at baseline and after 1, 2, and 3 years in a sample of 99 LOAD patients. These subjects were drug naive and had undergone the first clinical examination for the diagnosis of AD.
A multiple regression analysis indicated that the presence of ApoE epsilon4 allelic variant or GSTT1 null phenotype predicted the faster age at onset of the illness (F = 5.76, df = 2, 96, p = 0.0043). Carriers of GSTP1 *C allelic variant had a faster decline in cognitive functions (repeated measures analysis of variance [ANOVA]: F = 4.00, df = 3, 285, p = 0.008) and in BADLs (repeated measures ANOVA: F = 5.27, df = 3, 285, p = 0.001). This faster decline was independent from ApoE epsilon4 allele possession. No effect of GST P1-M1-T1 polymorphisms was found on behavioral symptom severity.
These data are in line with the hypotheses that oxidative damage is a prominent feature in the clinical progression and the age at onset of LOAD.
氧化应激被认为是阿尔茨海默病(AD)神经退行性变的一个促成因素,尤其是在晚发性AD(LOAD)患者中。因此,作者研究了谷胱甘肽S-转移酶(GST)P1-M1-T1基因多态性及其与载脂蛋白E(ApoE)ε4等位基因变异对AD三年纵向病程的影响。
在99例LOAD患者样本中,于基线时以及1年、2年和3年后,通过简易精神状态检查评估整体认知水平,通过身体自我维持量表评估日常生活基本活动能力(BADLs),通过神经精神科问卷评估行为。这些受试者未服用过药物,且已接受首次临床检查以诊断AD。
多元回归分析表明,ApoE ε4等位基因变异或GSTT1无效表型的存在预示着发病年龄更快(F = 5.76,自由度 = 2, 96,p = 0.0043)。GSTP1 *C等位基因变异携带者的认知功能下降更快(重复测量方差分析[ANOVA]:F = 4.00,自由度 = 3, 285,p = 0.008),BADLs下降也更快(重复测量ANOVA:F = 5.27,自由度 = 3, 285,p = 0.001)。这种更快的下降与是否拥有ApoE ε4等位基因无关。未发现GST P1-M1-T1多态性对行为症状严重程度有影响。
这些数据符合氧化损伤是LOAD临床进展和发病年龄的一个突出特征这一假设。